SANFORD R. SIMON - Corporate Board Profile

APPLIED DNA SCIENCES INC

Filing Date	Source Excerpt
2015-05-06	Dr. Sanford R. Simon has been a member of the Board of Directors since March 17, 2006. Dr. Simon has been a Professor of Biochemistry, Cell Biology and Pathology at Stony Brook since 1997. During the fiscal year ended September 30, 2014, we did not provide any cash compensation to our non-employee directors for their service on our Board of Directors. On November 30, 2011, the Board approved the recommendation from the Compensation Committee that each of the non-employee directors shall annually receive, for as long as they are a member of the Board, a 5-year stock option, fully vested after one year, to purchase a number of shares of common stock having a fair value of $60,000 as determined using the Black Scholes value, or as determined by the Compensation Committee.
2016-04-21	Dr. Sanford R. Simon has been a member of the Board of Directors since March 17, 2006. Dr. Simon has been a Professor of Biochemistry, Cell Biology and Pathology at Stony Brook since 1997. He joined the faculty at Stony Brook as an Assistant Professor in 1969 and was promoted to Associate Professor with tenure in 1975. Dr. Simon was a member of the Board of Directors of The Collaborative Group from 1995 to 2004. From 1967 to 1969, Dr. Simon was a Guest Investigator at Rockefeller University. Dr. Simon received a B.A. in Zoology and Chemistry from Columbia University in 1963, a Ph.D. in Biochemistry from Rockefeller University in 1967, and studied as a postdoctoral fellow with Nobel Prize winner Max Perutz in Cambridge, England. He maintains an active research laboratory studying aspects of cell invasion in cancer and inflammation and novel strategies of drug delivery; he also teaches undergraduate, graduate, medical and dental students. Dr. Simon is an expert at the use of large biomolecules in commercial media, and we have made use of his expertise in formulating DNA into commercial carriers for specific customers. As a member of our Board, Dr. Simon has advised us on patents, provided technical advice, and introduced us to corporate partners and customers. Our Board believes that Dr. Simon’s professional experience, expertise, and education make him an important contributor to our Board.
2017-01-26	Dr. Sanford R. Simon has been a member of the Board of Directors since March 17, 2006. Dr. Simon has been a Professor of Biochemistry, Cell Biology and Pathology at Stony Brook since 1997. He joined the faculty at Stony Brook as an Assistant Professor in 1969 and was promoted to Associate Professor with tenure in 1975. Dr. Simon was a member of the Board of Directors of The Collaborative Group from 1995 to 2004. From 1967 to 1969, Dr. Simon was a Guest Investigator at Rockefeller University. Dr. Simon received a B.A. in Zoology and Chemistry from Columbia University in 1963, a Ph.D. in Biochemistry from Rockefeller University in 1967, and studied as a postdoctoral fellow with Nobel Prize winner Max Perutz in Cambridge, England. He maintains an active research laboratory studying aspects of cell invasion in cancer and inflammation and novel strategies of drug delivery; he also teaches undergraduate, graduate, medical and dental students. Dr. Simon is an expert at the use of large biomolecules in commercial media, and we have made use of his expertise in formulating DNA into commercial carriers for specific customers. As a member of our Board, Dr. Simon has advised us on patents, provided technical advice, and introduced us to corporate partners and customers. Our Board believes that Dr. Simon’s professional experience, expertise, and education make him an important contributor to our Board.
2018-01-16	Dr. Sanford R. Simon has been a member of the Board of Directors since March 17, 2006... The table above includes the incremental fair value related to the modification of $16,059 for each director.
2019-04-04	Dr. Sanford R. Simon has been a member of the Board of Directors since March 17, 2006. ... Dr. Simon is an expert at the use of large biomolecules in commercial media, and we have made use of his expertise in formulating DNA into commercial carriers for specific customers. ... Director Compensation: Fiscal 2018 ... Sanford R. Simon ... Option Awards ($) 80,404 ... Total ($) 80,404.
2019-10-08	Sanford R. Simon
2020-08-03	Dr. Sanford R. Simon has been a member of the Board of Directors since March 17, 2006. ... The Board of Directors believes that Dr. Simon's advice makes him a valuable member of the Board of Directors. ... An option to purchase 4,970 shares of our common stock was granted to ... Mr. Simon ... at an exercise price of $22.40 per share. ... The amounts represent the grant date fair value calculated in accordance with ASC 718 based on the Black Scholes value of the options on the grant date.
2021-08-03	Dr. Sanford R. Simon has been a member of the Board of Directors since March 17, 2006. ... The Board of Directors believes that Dr. Simon’s advice makes him a valuable member of the Board of Directors. ... The membership of each of the audit committee, the compensation committee, and the nominating committee is composed, and was composed during the fiscal year ended September 30, 2020, entirely of independent directors. ... An option to purchase 13,606 shares of our common stock was granted to Mr. Simon on May 22, 2020, at an exercise price of $11.04 per share. ... Director Compensation: Fiscal 2020 ... Mr. Simon's total compensation was $135,000.
2022-07-29	Dr. Sanford R. Simon has been a member of the Board of Directors since March 17, 2006. ... The Board of Directors believes that Dr. Simon’s advice makes him a valuable member of the Board of Directors.
2022-08-10	Dr. Sanford R. Simon has been a member of the Board of Directors since March 17, 2006. ... Dr. Simon has worked in the use of large biomolecules in commercial media, and we have made use of his expertise in formulating DNA into commercial carriers for specific customers. ... Messrs. Shamash (Chairperson), Bitzer and Simon served during the fiscal year ended September 30, 2021, and Messrs. Shamash and Simon currently continue to serve, on the nominating committee.
2023-08-08	Dr. Sanford R. Simon has been a member of the Board of Directors since March 17, 2006. ... Dr. Simon has worked in the use of large biomolecules in commercial media, and we have made use of his expertise in formulating DNA into commercial carriers for specific customers. ... The Board of Directors believes that Dr. Simon’s advice makes him a valuable member of the Board of Directors.
2024-03-14	Sanford R. Simon Common Stock 167,103(6)
2024-08-21	Dr. Sanford R. Simon has been a member of the Board of Directors since March 17, 2006. Dr. Simon was a Professor of Biochemistry, Cell Biology and Pathology at Stony Brook. None of the members of our Board of Directors received any other compensation in respect of fiscal 2023. In fiscal 2023, on January 25, 2023, we granted an Option to purchase 5,632 shares of our Common Stock (having a grant date fair value of $150,000) to each of our non-employee directors, in respect of fiscal year 2023.